Health
Ask A Vaccine Specialist: What Does The Future of the mRNA Platform Hold? – The Motley Fool
Its use in a coronavirus vaccine is an exciting step forward, but mRNA technology is unlikely to solve all of our problems.
Recently authorized coronavirus vaccines from Moderna (NASDAQ:MRNA) and the Pfizer(NYSE:PFE)-BioNTech(NASDAQ:BNTX) team are the first messenger RNA (mRNA) vaccines ever to be commercialized. Dr. Bruce Gellin of the Sabin Vaccine Institute joined Corinne Cardina and Olivia Zitkus of Fool.com’s Healthcare and Cannabis Bureau on a Dec. 18 episode of Fool Live to talk about some of the possibilities of the mRNA platform in vaccine and drug development.
Olivia Zitkus: As an expert on these vaccines,…
-
General11 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
Noosa News22 hours agoDeaths of Karen Edwards, Tim Thomson, and Gordon Twaddle re-examined in inquest
-
Noosa News23 hours agoSecond inquest into homicide of three tourists shot dead Mount Isa in 1978 begins
-
General23 hours agoThe Church of England’s ‘turning point’ to irrelevancy